Dr. James Shannon of Novartis tells NGP about the advantages its new diabetes treatments will bring to patients.
What are some of the biggest staffing challenges within the biopharmaceutical industry? NGP asked Vinay Nayak, Aerotek’s VP of Sales for Life Sciences.
Fraser Black of GE Healthcare talks to NGP about scientific asset services and the advantages of outsourcing asset management.
NGP speaks with Judith Sills, VP of Medical Safety Operations in the Integrated Medical Safety department at Novartis Pharmaceuticals, about the changing dynamics of drug safety and Novartis’ integrated lifecycle approach to drug safety.